1. PI3K/Akt/mTOR
  2. PI3K
  3. IHMT-PI3K-455

IHMT-PI3K-455 (Compound 15u) is a potent, selective, orally active PI3Kγ/δ dual inhibitor with IC50s of 7.1 nM and 0.57 nM for PI3Kγ and PI3Kδ, respectively. IHMT-PI3K-455 suppresses the AKT phosphorylation. IHMT-PI3K-455 inhibits tumor growth by recruiting and activating more CD8+ killing T cells.IHMT-PI3K-455 is used in cancer research.

For research use only. We do not sell to patients.

IHMT-PI3K-455 Chemical Structure

IHMT-PI3K-455 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

IHMT-PI3K-455 (Compound 15u) is a potent, selective, orally active PI3Kγ/δ dual inhibitor with IC50s of 7.1 nM and 0.57 nM for PI3Kγ and PI3Kδ, respectively. IHMT-PI3K-455 suppresses the AKT phosphorylation. IHMT-PI3K-455 inhibits tumor growth by recruiting and activating more CD8+ killing T cells.IHMT-PI3K-455 is used in cancer research[1].

IC50 & Target

PI3Kα

6.717 μM (IC50)

PI3Kβ

42.04 nM (IC50)

PI3Kγ

7.1 nM (IC50)

PI3Kδ

0.57 nM (IC50)

In Vitro

IHMT-PI3K-455 (1 μM, 2 h) suppresses the PI3Kγ/δ-mediated AKT phosphorylation in RAW264.7 cells and Raji cells[1].
IHMT-PI3K-455 (1 μM, 72 h) alters the macrophage polarization in M2 macrophages derived from THP-1 and BMDM cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Differentiation Assay[1]

Cell Line: Macrophages
Concentration: 0.1, 1 μM
Incubation Time: 72 h
Result: Increased the proinflammatory M1 macrophage phenotype in a dose-dependent manner, with a concomitant dose-dependent decrease of the anti-inflammatory M2 macrophage phenotype.
Repolarized M2 phenotype toward M1 phenotype in THP-1 and BMDM macrophages.

Western Blot Analysis[1]

Cell Line: RAW264.7 cells; Raji cells
Concentration: 0, 0.01, 0.03, 0.1, 0.3, 1 μM
Incubation Time: 2 h
Result: Potently inhibited the PI3Kγ-mediated AKT473 phosphorylation in RAW264.7 cells (human C5a stimulation) with an IC50 value of 0.015 μM.
Potently inhibited the PI3Kδ-mediated AKT473 phosphorylation in Raji cells (anti-IgM stimulation) with an IC50 value of 0.010 μM.
In Vivo

IHMT-PI3K-455 (40 mg/kg for p.o; once daily for 30 days) inhibits the tumor growth in a MC38 tumor xenograft model[1].
IHMT-PI3K-455 (40 mg/kg for p.o; once daily for 30 days) inhibits tumor growth by recruiting and activating more CD8+ killing T cells[1].
Pharmacokinetic parameters of IHMT-PI3K-455 in Sprague-Dawley rats[1]

Dose (mg/kg) Administration route Cmax (ng/mL) Tmax (h) AUC0-∞ (h⋅ng/mL) T1/2 (h) CL (L/h/kg) Vz (L/kg) F (%)
1 i.v. 1233 0.03 477 1.59 2.12 4.80
10 p.o. 157 3.42 838 2.71 14.76 56.02 17.6

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MC38 tumor model[1]
Dosage: 10 mg/kg, 40 mg/kg
Administration: Oral gavage (p.o.); Once daily for 30 days
Result: Significantly inhibited tumor size in a dose-dependent manner.
Increased tumor-infiltrating CD8+T cells.
Molecular Weight

517.49

Formula

C26H21F2N7O3

SMILES

COC1=C(OC)N=CC(C2=NC3=CC(NC4=CC=CC(CNC(C5=C(F)C=CC=C5F)=O)=N4)=NN3C=C2)=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email Address *

Phone Number *

 

Organization Name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
IHMT-PI3K-455
Cat. No.:
HY-149493
Quantity:
MCE Japan Authorized Agent: